Literature DB >> 19296466

Taurine supplementation prevents ethanol-induced decrease in serum adiponectin and reduces hepatic steatosis in rats.

Xiaocong Chen1, Becky M Sebastian, Hui Tang, Megan M McMullen, Armend Axhemi, Donald W Jacobsen, Laura E Nagy.   

Abstract

UNLABELLED: Chronic ethanol feeding decreases expression of adiponectin by adipocytes and circulating adiponectin. Adiponectin treatment during chronic ethanol feeding prevents liver injury in mice. Chronic ethanol feeding also increases oxidative and endoplasmic reticulum (ER) stress in adipose tissue. Here we tested the hypothesis that supplemental taurine, an amino acid that functions as a chemical chaperone/osmolyte and enhances cellular antioxidant activity, would prevent ethanol-induced decreases in adiponectin expression and attenuate liver injury. Serum adiponectin concentrations decreased as early as 4 to 7 days after feeding rats a 36% ethanol diet. This rapid decrease was associated with increased oxidative, but not ER, stress in subcutaneous adipose tissue. Taurine prevented ethanol-induced oxidative stress and increased inflammatory cytokine expression in adipose tissue. Ethanol feeding also rapidly decreased expression of transcription factors regulating adiponectin expression (CCAAT/enhancer binding protein alpha; peroxisome proliferator-activated receptor alpha/gamma) in subcutaneous adipose tissue. Taurine prevented the ethanol-induced decrease in CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor alpha, normalizing adiponectin messenger (m)RNA and serum adiponectin concentrations. In the liver, taurine prevented ethanol-induced oxidative stress and attenuated tumor necrosis factor alpha expression and steatosis, at least in part, by increasing expression of genes involved in fatty acid oxidation.
CONCLUSION: In subcutaneous adipose tissue, taurine decreased ethanol-induced oxidative stress and cytokine expression, as well as normalized expression of adiponectin mRNA. Taurine prevented ethanol-induced decreases in serum adiponectin; normalized adiponectin was associated with a reduction in hepatic oxidative stress, tumor necrosis factor alpha expression, and steatosis. Taken together, these data demonstrate that taurine has important protective effects against ethanol-induced tissue injury in both adipose and liver tissue.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19296466      PMCID: PMC2677130          DOI: 10.1002/hep.22811

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  41 in total

Review 1.  Adipose tissue as an endocrine organ.

Authors:  Erin E Kershaw; Jeffrey S Flier
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

2.  Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats.

Authors:  K C Choi; O H Ryu; K W Lee; H Y Kim; J A Seo; S G Kim; N H Kim; D S Choi; S H Baik; K M Choi
Journal:  Biochem Biophys Res Commun       Date:  2005-10-28       Impact factor: 3.575

3.  Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

Authors:  K Hotta; T Funahashi; Y Arita; M Takahashi; M Matsuda; Y Okamoto; H Iwahashi; H Kuriyama; N Ouchi; K Maeda; M Nishida; S Kihara; N Sakai; T Nakajima; K Hasegawa; M Muraguchi; Y Ohmoto; T Nakamura; S Yamashita; T Hanafusa; Y Matsuzawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-06       Impact factor: 8.311

Review 4.  Adiponectin and adiponectin receptors.

Authors:  Takashi Kadowaki; Toshimasa Yamauchi
Journal:  Endocr Rev       Date:  2005-05       Impact factor: 19.871

5.  Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice.

Authors:  Min You; Robert V Considine; Teresa C Leone; Daniel P Kelly; David W Crabb
Journal:  Hepatology       Date:  2005-09       Impact factor: 17.425

Review 6.  Recent advances in alcoholic liver disease II. Minireview: molecular mechanisms of alcoholic fatty liver.

Authors:  Min You; David W Crabb
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-07       Impact factor: 4.052

7.  Obesity is associated with macrophage accumulation in adipose tissue.

Authors:  Stuart P Weisberg; Daniel McCann; Manisha Desai; Michael Rosenbaum; Rudolph L Leibel; Anthony W Ferrante
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

Review 8.  Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes.

Authors:  Adilson Guilherme; Joseph V Virbasius; Vishwajeet Puri; Michael P Czech
Journal:  Nat Rev Mol Cell Biol       Date:  2008-05       Impact factor: 94.444

Review 9.  Molecular aspects of alcohol metabolism: transcription factors involved in early ethanol-induced liver injury.

Authors:  Laura E Nagy
Journal:  Annu Rev Nutr       Date:  2004       Impact factor: 11.848

10.  Adipocyte determination- and differentiation-dependent factor 1/sterol regulatory element-binding protein 1c regulates mouse adiponectin expression.

Authors:  Jong Bae Seo; Hyang Mi Moon; Mun Ju Noh; Yun Sok Lee; Hyun Woo Jeong; Eung Jae Yoo; Woo Sik Kim; Jiyoung Park; Byung-S Youn; Jae Woo Kim; Sang Dai Park; Jae Bum Kim
Journal:  J Biol Chem       Date:  2004-03-22       Impact factor: 5.157

View more
  42 in total

Review 1.  Mechanisms of alcohol-mediated hepatotoxicity in human-immunodeficiency-virus-infected patients.

Authors:  Gyongyi Szabo; Samir Zakhari
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

2.  Experimental evidence for therapeutic potential of taurine in the treatment of nonalcoholic fatty liver disease.

Authors:  Christopher L Gentile; Angela M Nivala; Jon C Gonzales; Kyle T Pfaffenbach; Dong Wang; Yuren Wei; Hua Jiang; David J Orlicky; Dennis R Petersen; Michael J Pagliassotti; Kenneth N Maclean
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-09-28       Impact factor: 3.619

3.  Alcohol-induced adipose tissue macrophage phenotypic switching is independent of myeloid Toll-like receptor 4 expression.

Authors:  Melissa A Fulham; Anuradha Ratna; Rachel M Gerstein; Evelyn A Kurt-Jones; Pranoti Mandrekar
Journal:  Am J Physiol Cell Physiol       Date:  2019-07-03       Impact factor: 4.249

4.  Proteasome inhibitor treatment reduced fatty acid, triacylglycerol and cholesterol synthesis.

Authors:  Joan Oliva; Samuel W French; Jun Li; Fawzia Bardag-Gorce
Journal:  Exp Mol Pathol       Date:  2012-03-16       Impact factor: 3.362

Review 5.  Bioactive oxidatively truncated phospholipids in inflammation and apoptosis: formation, targets, and inactivation.

Authors:  Thomas M McIntyre
Journal:  Biochim Biophys Acta       Date:  2012-03-16

6.  Nanoformulated SOD1 ameliorates the combined NASH and alcohol-associated liver disease partly via regulating CYP2E1 expression in adipose tissue and liver.

Authors:  Thiyagarajan Gopal; Narendra Kumar; Curtis Perriotte-Olson; Carol A Casey; Terrence M Donohue; Edward N Harris; Geoffrey Talmon; Alexander V Kabanov; Viswanathan Saraswathi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-13       Impact factor: 4.052

7.  Chronic ethanol ingestion induces oxidative kidney injury through taurine-inhibitable inflammation.

Authors:  Calivarathan Latchoumycandane; Laura E Nagy; Thomas M McIntyre
Journal:  Free Radic Biol Med       Date:  2014-01-08       Impact factor: 7.376

8.  Role of Mitochondria in Alcoholic Liver Disease.

Authors:  Carmen García-Ruiz; Neil Kaplowitz; José C Fernandez-Checa
Journal:  Curr Pathobiol Rep       Date:  2013-09-01

9.  Involvement of adiponectin-SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice.

Authors:  Zheng Shen; Xiaomei Liang; Christopher Q Rogers; Drew Rideout; Min You
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-12-10       Impact factor: 4.052

10.  C/EBP beta and C/EBP delta expression is elevated in the early phase of ethanol-induced hepatosteatosis in mice.

Authors:  Yu-hsuan Chen; Chih-min Yang; Shih-pei Chang; Miao-lin Hu
Journal:  Acta Pharmacol Sin       Date:  2009-07-20       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.